Skip to main content
. 2003 Jan;47(1):196–203. doi: 10.1128/AAC.47.1.196-203.2003

TABLE 2.

HA-MRSA isolates analyzed in this study

Isolatea Resistance phenotypeb Presence of SAgc
PFGE type Source
SEB SEC TSST-1
U634 POxEClC B1 Right knee
U655 POxEClC B1 Body fluid
U652 POxEClC Unique Right eye
U639 POxEClC Unique Nasal wash
U661 POxEClC Unique Wound
U660 POxEC Unique Wound
U640 POxEClC Unique Blood
U609 POx Unique Sputum
U657 POx Unique Finger
U667 POxEClCGSxt B2 Bronchoalveolar lavage
U473 POxEClCGSxt Unique Sputum
U480 POxEClC B6 Blood
U479 POxEClC B2 Sputum
U494 POxEClCRCh B5 Blood
U492 POxEClCR B5 Sputum
U487 POxEClCRChGSxt B5 Sputum
U601 POxEClCGSxt B2 Blood
U605 POxEClC B4 Sputum
U674 POxEClC B3 Wound
U472 POxEClC B4 Catheter tip
U622 POxEClC Unique Sputum
U621 POxEClC Unique Blood
U630 POx Unique Wound
U628 POxEClC Unique Sputum
U604 POxEClC B6 Sputum
U619 POxEClC B2 Blood
U625 POxEClC B2 Blood
U627 POxEClC B2 Abdomen
U599 POxEClCG B3 Blood
U657 POx Unique Finger
U613 POxEClC Unique Sputum
U632 POxEClC B2 Abdomen
a

U = hospital-acquired isolates.

b

P, penicillin; Ox, oxacillin; E, erythromycin; C, ciprofloxacin; Cl, clindamycin; Ch, chloramphenicol; G, gentamicin; Sxt, trimethoprim-sulfamethoxazole; and R, rifampin.

c

+, positive; −, negative.

d

“Unique” represents a PFGE pattern that was distinguishable from all other isolates in the present study, as represented by Fig. 1.

HHS Vulnerability Disclosure